|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 68.07 USD | -4.11% |
|
-6.96% | -16.87% |
Chart calendar Tarsus Pharmaceuticals, Inc.
Upcoming events on Tarsus Pharmaceuticals, Inc.
No events available
Past events on Tarsus Pharmaceuticals, Inc.
| 2026-08-06 | Earnings release - Q2 2026 | |
| 2026-08-06 | Earnings presentation | 08:00 |
| 2026-06-25 | Présentation aux Actionnaires / Analystes | 12:00 |
| 2026-06-25 | Annual General Meeting | 12:00 |
| 2026-05-06 | Earnings presentation | 16:30 |
| 2026-05-06 | Earnings release - Q1 2026 | |
| 2026-02-23 | Earnings release - Q4 2025 | |
| 2026-02-23 | Earnings presentation | 16:30 |
| 2025-11-04 | Earnings presentation | 16:30 |
| 2025-11-04 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17,4 9,70 79.91% | 183 175 4.26% | 451 444 1.62% | 727 | 920 | 1 141 |
|
EBITDA Million USD | Released Forecast Spread | -142 -138 -3.02% | -120 -121 1.21% | -69,2 -62,8 -10.04% | -94,3 | 45,4 | 124 |
|
EBIT Million USD | Released Forecast Spread | -143 -144 0.6% | -121 -125 3.47% | -71,0 -68,7 -3.3% | -215 | 8,85 | 154 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -136 -137 0.83% | -116 -121 4.44% | -64,4 -57,3 -12.25% | -232 | 56,9 | 213 |
|
Net income Million USD | Released Forecast Spread | -136 -137 0.96% | -116 -119 3.06% | -66,4 -63,3 -4.84% | -215 | 9,62 | 203 |
|
EPS USD | Released Forecast Spread | -4,62 -4,79 3.52% | -3,07 -3,16 2.85% | -1,59 -1,50 -5.77% | -4,79 | 0,13 | 3,60 |
| Announcement Date | 27/02/24 | 25/02/25 | 23/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 66,4 58,8 12.93% | 78,3 72,5 8.09% | 103 95,8 7.14% | 119 115 3.02% | 152 145 4.91% | 162 148 9.65% | 174 170 2.59% | 187 | 203 | 198 | 227 | 230 | 255 |
|
EBITDA Million USD | Released Forecast Spread | 18,9 | -70,8 | 0,78 | -10,1 | 13,9 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -24,4 -28,7 15.02% | -26,3 -29,5 10.8% | -22,2 -18,4 -20.3% | -14,5 -17,3 15.98% | -7,98 -7,07 -12.75% | -6,12 -20,3 69.77% | -19,9 -8,71 -128.69% | -75,8 | -113 | -20,1 | -1,59 | -11,1 | 2,20 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,1 -32,9 29.66% | -25,1 -34,7 27.68% | -20,3 -18,8 -8.09% | -12,6 -17,4 27.51% | -6,31 -0,18 -3508% | -4,62 -23,9 80.66% | -15,8 -8,83 -79.38% | -68,1 | -215 | ||||
|
Net income Million USD | Released Forecast Spread | -23,1 -26,7 13.57% | -25,1 -29,4 14.7% | -20,3 -17,4 -16.81% | -12,6 -16,5 23.57% | -8,37 -7,47 -12.08% | -6,97 -20,2 65.44% | -18,6 -8,83 -110.14% | -77,1 | -215 | ||||
|
EPS USD | Released Forecast Spread | -0,60 -0,67 11.02% | -0,64 -0,74 13.9% | -0,48 -0,38 -27.43% | -0,30 -0,34 12.62% | -0,20 -0,13 -53.85% | -0,16 -0,48 66.86% | -0,43 -0,20 -115% | -1,66 | -3,17 | -0,19 | 0,28 | -0,45 | -0,26 |
| Announcement Date | 25/02/25 | 01/05/25 | 06/08/25 | 04/11/25 | 23/02/26 | 06/05/26 | 06/08/26 | - | - | - | - | - | - |
| 2026-10-21 | Earnings release - Q3 2026 | ||
| 2026-10-21 | Earnings release - Q3 2026 | ||
| 2026-10-22 | Earnings release - Q3 2026 | ||
| 2026-10-22 | Earnings presentation | 04:00 | |
| 2026-10-22 | Earnings release - Q3 2026 | ||
| 2026-10-22 | Earnings release - Q3 2026 | 02:00 | |
| 2026-10-22 | Earnings presentation | 03:30 | |
| 2026-10-23 | Earnings release - Q3 2026 | ||
| 2026-10-23 | Earnings release - Q3 2026 | ||
| 2026-10-23 | Information meeting | 08:00 |
Past sector events for Tarsus Pharmaceuticals, Inc.
| 2026-10-15 | Extraordinary General Meeting | 03:00 | |
| 2026-10-15 | Extraordinary General Meeting | 02:00 | |
| 2026-10-13 | Sales and Revenue Release - Q3 2026 | ||
| 2026-10-13 | Extraordinary General Meeting | 02:30 | |
| 2026-10-12 | Extraordinary General Meeting | 21:30 | |
| 2026-10-09 | Earnings presentation | 03:00 | |
| 2026-10-09 | Extraordinary General Meeting | 02:30 | |
| 2026-10-08 | Earnings presentation | 21:00 | |
| 2026-10-02 | Ex-dividend date - 0.99325 KRW | 00:00 | |
| 2026-10-01 | Information meeting | 08:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
- Calendar Tarsus Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
















